ConductScience.org, home

Paper17519436

Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials.

Balk EM and 4 others. Diabetes Care, 2007. Cited by 171 papers, by iCite.

Cite this record

ConductScience Library. Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Papers, record 17519436. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17519436

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials.
PubMed
Journal
Diabetes Care
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S., Systematic Review
PubMed
Citations, by iCite
171
iCite
Relative citation ratio, by iCite
5.21
iCite
Revised in PubMed
2025-06-23
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Balk EMEthan M
2Tatsioni AAthina
3Lichtenstein AHAlice H
4Lau JJoseph
5Pittas AGAnastassios G

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood GlucoseMajor topic
ChromiumMajor topic
Dietary SupplementsMajor topic
Humans
Randomized Controlled Trials as Topic
Reproducibility of Results
Saccharomyces cerevisiae

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K23 DK061506NIDDK NIH HHSUnited StatesK23DK061506PubMed and NIHNIH RePORTER
AHRQ 290-02-0023PHS HHSUnited StatesPubMedPubMed
K23-DK61506NIDDK NIH HHSUnited StatesK23DK061506PubMed and NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in17726181Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials.https://conductscience.org/library/papers/17726181

Source PubMed

Download CSV of comments and corrections

Cited by87

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 171 citations.

PMIDTitleJournalYearIn PapersSource
42591408Dietary bioactive compounds targeting insulin resistance: mechanisms and preventive potential.Front Nutr2026https://conductscience.org/library/papers/42591408PubMed
42163851Chromium as a Modulator of Insulin Receptor Activity: A Systematic Review of Its Role in Metabolic Syndrome and Type 2 Diabetes.Diabetes Metab Syndr Obes2026https://conductscience.org/library/papers/42163851PubMed
42075041Evaluating Large Language Models for Food Supplement Development: A Case Study in Glycemic Control.Nutrients2026https://conductscience.org/library/papers/42075041PubMed
41376013Exfoliated Graphite as a Solid Sorbent in Ultrasound-Assisted Dispersive Micro-Solid-Phase Extraction for Determination of Chromium and Vanadium in Herbs.Foods2025https://conductscience.org/library/papers/41376013PubMed
41073120Evaluating diabetes-specific meal replacements for glycaemic control in overweight and obese patients with T2DM: a protocol for a randomised controlled trial.BMJ Open2025https://conductscience.org/library/papers/41073120PubMed
41009549Environmental Insults to Glucose Metabolism: The Role of Pollutants in Insulin Resistance.Int J Mol Sci2025https://conductscience.org/library/papers/41009549PubMed
40817355Medical nutrition therapy for the management of type 2 diabetes mellitus.Nat Rev Endocrinol2025https://conductscience.org/library/papers/40817355PubMed
40551695Modern Approaches to Diabetes: The Role of Phytochemicals in Targeting Molecular Receptors.Curr Top Med Chem2025https://conductscience.org/library/papers/40551695PubMed
40490608Impact of a mineral enriched, fiber complex on glycaemic response and satiation in healthy adults: a double-blind, crossover intervention study.Eur J Nutr2025https://conductscience.org/library/papers/40490608PubMed
40376080Dietary Antioxidant Minerals (Cr, Mg, Cu, Se, Zn) in Diabetic Children and their Relationship with Fasting and Postprandial Blood Glucose.Int J Prev Med2025https://conductscience.org/library/papers/40376080PubMed
40345207The Potential Benefits of Chromium and Selenium Supplementation Across Psychiatric Disorders and Symptoms.J Clin Psychopharmacol2025https://conductscience.org/library/papers/40345207PubMed
39541030Chromium supplementation and type 2 diabetes mellitus: an extensive systematic review.Environ Geochem Health2024https://conductscience.org/library/papers/39541030PubMed
38140355Nutritional Strategies for the Management of Type 2 Diabetes Mellitus: A Narrative Review.Nutrients2023https://conductscience.org/library/papers/38140355PubMed
37432389Beta Cell Dysfunction in Youth- and Adult-Onset Type 2 Diabetes: An Extensive Narrative Review with a Special Focus on the Role of Nutrients.Nutrients2023https://conductscience.org/library/papers/37432389PubMed
37396849Disease-associated metabolic pathways affected by heavy metals and metalloid.Toxicol Rep2023https://conductscience.org/library/papers/37396849PubMed
36701335
A low chromium diet increases body fat, energy intake and circulating triglycerides and insulin in male and female rats fed a moderately high-fat, high-sucrose diet from peripuberty to young adult age.
PLoS One2023https://conductscience.org/library/papers/36701335PubMed
36618526Maternal Chromium Levels in Gestational Diabetes: Systematic Review and Meta-Analysis.Indian J Endocrinol Metab2022https://conductscience.org/library/papers/36618526PubMed
36404841Therapeutic effects of dietary antioxidative supplements on the management of type 2 diabetes and its complications; umbrella review of observational/trials meta-analysis studies.J Diabetes Metab Disord2022https://conductscience.org/library/papers/36404841PubMed
36376714Effects of Chromium Supplementation on Lipid Profile: an Umbrella of Systematic Review and Meta-analysis.Biol Trace Elem Res2023https://conductscience.org/library/papers/36376714PubMed
36278758The Effects of Chromium and Vanadium on Biomarkers of Carbohydrate and Lipid Metabolism in Workers Exposed to Coal Fly Ash.J Xenobiot2022https://conductscience.org/library/papers/36278758PubMed

See all 87 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17519436

GET https://conductscience.org/api/papers/v1/17519436/cited_by?page=2